As I am very much of the cohort for which Viraleze is effective, I am thankful.
I should also observe as a lay person that the human immune system tends to get weaker as we get older, disregarding the effect of various acquired immunities. An example being the prevalence of shingles amongst older people, even amongst the majority who have had chicken pox.
One could therefore make a case for the lack of comparative effectiveness in younger folk being due to their immune systems being more capable of fighting the virus than the older cohort.
My advice to the company would be undertake further limited human clinical trials (they do not have to be huge) to:
1) Verify the preventative effect, in the same way as other prophylactics are being tested. and
2) Further test the treatment effectiveness.
I seriously doubt they will do this. But perhaps they should license the rights to a firm that will.
They should also use these results to bring pressure on the TGA. They will, of course have advised the TGA of these results as part of normal process.
- Forums
- ASX - By Stock
- SPL
- Ann: Viraleze shows antiviral efficacy in COVID-19 patients
Ann: Viraleze shows antiviral efficacy in COVID-19 patients, page-26
-
- There are more pages in this discussion • 49 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add SPL (ASX) to my watchlist
|
|||||
Last
9.5¢ |
Change
0.004(4.40%) |
Mkt cap ! $39.17M |
Open | High | Low | Value | Volume |
9.2¢ | 9.6¢ | 9.2¢ | $81.30K | 864.2K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 9.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
9.9¢ | 1285 | 1 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 28056 | 0.095 |
2 | 110498 | 0.094 |
1 | 26688 | 0.092 |
1 | 49413 | 0.091 |
4 | 122750 | 0.090 |
Price($) | Vol. | No. |
---|---|---|
0.099 | 1285 | 1 |
0.100 | 112106 | 4 |
0.105 | 66531 | 3 |
0.110 | 16500 | 2 |
0.115 | 109827 | 3 |
Last trade - 16.10pm 26/08/2024 (20 minute delay) ? |
Featured News
SPL (ASX) Chart |